1. Eli Lilly lowers insulin costs as coronavirus crisis deepens— IQVIA launches new COVID-19 trial matching service — Inovio begins clinical trial of COVID-19 vaccine — See more on our front page news Stay updated with the latest pharma-related coronavirus news on our new page
    Dismiss Notice
  2. Think you have witnessed fraud?Ask a Whistleblower Attorney -- a chance to discuss whistleblower-related legal issues with practicing whistleblower attorneys.
    Dismiss Notice

It’s Official

Discussion in 'Impax Labs/Global' started by anonymous, Apr 27, 2018 at 11:50 PM.

Tags: Add Tags
  1. anonymous

    anonymous Guest

    The Countdown Begins......

    We are now Amneal. What will the future hold? Managers turning the screws. Goals set by somebody just randomly throwing darts at unobtainable numbers. Territories being consolidated. A Bonus structure that is going to see more people getting paid less. Turnover rivaled only buy McDonalds. Morale in flux because there are so many people shuffling in and out.
    And we still have problems with getting providers to understand how to RX and getting covered.

    The more things change the more they stay the same
     

  2. anonymous

    anonymous Guest

    What exactly is the dosing schedule for Rytary? Thinking of trying something new for my dad but even his Neurologist was not sure how to dose it, said he has some patients on 20 or 24 pills/day. Thought this was an extended-release formulation CD/LD, will keep him on generic Sinemet for now, it is cheap and dosed less often.:(:(